These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH. Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180 [TBL] [Abstract][Full Text] [Related]
3. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer. Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203 [TBL] [Abstract][Full Text] [Related]
4. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760 [TBL] [Abstract][Full Text] [Related]
5. X chromosomal abnormalities in basal-like human breast cancer. Richardson AL; Wang ZC; De Nicolo A; Lu X; Brown M; Miron A; Liao X; Iglehart JD; Livingston DM; Ganesan S Cancer Cell; 2006 Feb; 9(2):121-32. PubMed ID: 16473279 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Rodríguez-Pinilla SM; Sarrió D; Honrado E; Hardisson D; Calero F; Benitez J; Palacios J Clin Cancer Res; 2006 Mar; 12(5):1533-9. PubMed ID: 16533778 [TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Pinilla SM; Honrado E; Hardisson D; Benítez J; Palacios J Breast Cancer Res Treat; 2006 Sep; 99(1):85-90. PubMed ID: 16541313 [TBL] [Abstract][Full Text] [Related]
9. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. Joosse SA; van Beers EH; Tielen IH; Horlings H; Peterse JL; Hoogerbrugge N; Ligtenberg MJ; Wessels LF; Axwijk P; Verhoef S; Hogervorst FB; Nederlof PM Breast Cancer Res Treat; 2009 Aug; 116(3):479-89. PubMed ID: 18704682 [TBL] [Abstract][Full Text] [Related]
10. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Wei M; Grushko TA; Dignam J; Hagos F; Nanda R; Sveen L; Xu J; Fackenthal J; Tretiakova M; Das S; Olopade OI Cancer Res; 2005 Dec; 65(23):10692-9. PubMed ID: 16322213 [TBL] [Abstract][Full Text] [Related]
11. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313 [TBL] [Abstract][Full Text] [Related]
12. BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype. Santarosa M; Maestro R Cancer Metastasis Rev; 2012 Jun; 31(1-2):131-42. PubMed ID: 22101651 [TBL] [Abstract][Full Text] [Related]
13. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Vincent-Salomon A; Gruel N; Lucchesi C; MacGrogan G; Dendale R; Sigal-Zafrani B; Longy M; Raynal V; Pierron G; de Mascarel I; Taris C; Stoppa-Lyonnet D; Pierga JY; Salmon R; Sastre-Garau X; Fourquet A; Delattre O; de Cremoux P; Aurias A Breast Cancer Res; 2007; 9(2):R24. PubMed ID: 17417968 [TBL] [Abstract][Full Text] [Related]
14. Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer. Ganesan S; Richardson AL; Wang ZC; Iglehart JD; Miron A; Feunteun J; Silver D; Livingston DM Cold Spring Harb Symp Quant Biol; 2005; 70():93-7. PubMed ID: 16869742 [TBL] [Abstract][Full Text] [Related]
15. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Alvarez S; Diaz-Uriarte R; Osorio A; Barroso A; Melchor L; Paz MF; Honrado E; Rodríguez R; Urioste M; Valle L; Díez O; Cigudosa JC; Dopazo J; Esteller M; Benitez J Clin Cancer Res; 2005 Feb; 11(3):1146-53. PubMed ID: 15709182 [TBL] [Abstract][Full Text] [Related]
16. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer. Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer. Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361 [TBL] [Abstract][Full Text] [Related]
19. The molecular pathology of hereditary breast cancer. Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963 [TBL] [Abstract][Full Text] [Related]
20. High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors. Manié E; Vincent-Salomon A; Lehmann-Che J; Pierron G; Turpin E; Warcoin M; Gruel N; Lebigot I; Sastre-Garau X; Lidereau R; Remenieras A; Feunteun J; Delattre O; de Thé H; Stoppa-Lyonnet D; Stern MH Cancer Res; 2009 Jan; 69(2):663-71. PubMed ID: 19147582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]